When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TKPHF - IPO Update: Freeline Therapeutics Proposes Terms For U.S. IPO
Takeda Pharmaceutical Co Ltd
Quick Take
Freeline Therapeutics Holdings plc (FRLN) intends to raise $125 million from the sale of ADSs representing underlying common stock in an IPO, according to an amended registration statement.
The company is advancing a pipeline of treatment candidates for hemophilia, Gaucher disease and Fabry disease.
FRLN has produced promising trial results to-date and an IPO valuation within range, so for life science investors with an 18 - 36-month hold time frame, the IPO may be worth a closer look.
Company & Technology
Hertfordshire, UK-based Freeline was founded to develop its AAV-based